Alumis

We are thrilled to announce our initial public offering, trading on Nasdaq under the ticker $ALMS! This achievement wouldn't have been possible without the relentless dedication of our incredible team, as well as the support of our Board of Directors and investors. Thank you to everyone who helped us reach this critical milestone in support of our mission to improve the lives of patients with immune-mediated diseases. #NasdaqListed

Today we announced the pricing of our initial public offering: https://bit.ly/3zwhdvh #NasdaqListed

Alumis’ clinical development team attended the EULAR - European Alliance of Associations for Rheumatology 2024 Congress earlier this month in Vienna! With the goal of driving progress in the clinical care of people with rheumatic diseases, the annual meeting brings together patients, health professionals, rheumatologists and industry partners to showcase the latest scientific breakthroughs in clinical, translational, and basic research. We were thrilled to be part of this meeting as we advance our #lupus clinical trial LUMUS! #EULAR2024

Today, we honor #Juneteenth, celebrating freedom, resilience, and progress. As we reflect on this important day in history, we’re committed to fostering diversity and inclusion at Alumis. #FreedomDay

This #PrideMonth, we celebrate the vibrant LGBTQIA+ community and recognize their invaluable contributions to science and biotechnology. Together, we stand proud in our commitment to diversity, inclusion, and equality. #Pride2024

As #LupusAwarenessMonth comes to a close, we're inspired by the resilience and strength of the #lupus community. At Alumis, we're honored be part of the research community dedicated to advancing effective treatment options for people living with lupus. We recognize the global impact of lupus and will continue to focus on the advancement of our lupus clinical program with the goal of make a difference for the lupus community worldwide! #LupusAwareness #LupusResearch

Did you know that women are disproportionately affected by #lupus? To learn more about lupus this #LupusAwarenessMonth, check out resources and information from @LupusResearch: https://lnkd.in/esmUVvvw 

At Alumis, our aim is clear: to make a tangible difference for the #lupus community. This #LupusAwarenessMonth, we recognize the dedication of our employees who have devoted their careers to understanding this challenging disease as researchers, clinicians, and patient advocates. We are putting on purple – the color of Lupus Awareness Month – to raise awareness and drive forward clinical research so everyone with lupus can envision a brighter future! #LupusResearch #MakeLupusVisible

This May, we're proud to celebrate Asian American, Native Hawaiian and Pacific Islander Heritage Month! At Alumis, we honor the rich cultural diversity and invaluable contributions of the #AANHPI community that have driven innovation and progress in biotechnology, healthcare, and beyond. #AANHPIHeritageMonth #AANHPIMonth

Last week, the Alumis team attended the 4th Annual #Lupus Clinical Investigators Network (LuCIN) Community Meeting with Lupus Research Alliance alongside clinical investigators, study coordinators, individuals living with lupus, and industry partners for insightful discussions on critical research initiatives and cutting-edge approaches in lupus treatment. Learn more: https://bit.ly/LuCIN2024 #LupusResearch #LupusAwarenessMonth